Patents by Inventor Lance Toland

Lance Toland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250120421
    Abstract: The invention presents a novel feed formulation and processing optimized for horseshoe crabs in prolonged captivity, with application to myriad species. The formulation is not only sustainable but environmentally advantageous at scale by utilizing fish and poultry processing by-products. The nutrient-rich waste products are enhanced through cold-processed, enzymatic liquefication and fermentation, which preserves proteins and vitamins and thus, nutrient integrity and bioavailability. The formulation is matched to the composition of the horseshoe crab and the flora and fauna of its habitat diet. Feed efficacy can be measured by observed attraction and palatability, as well as parameters including but not limited to cellular integrity and amebocyte reactivity, weight, disease resistance, and carapace metrics.
    Type: Application
    Filed: October 16, 2023
    Publication date: April 17, 2025
    Inventors: Rachel Tinker-Kulberg, Anthony Lee Dellinger, Terry Earl Brady, Melinda K. M. Goddard, Lance Toland, Christopher L. Kepley
  • Publication number: 20240382535
    Abstract: This invention relates to a broad-spectrum antimicrobial marine biologic composition for bloodstream infections, derived from smeLAL and optional hemolymph of sustainable aquaculture horseshoe crabs. The formulation serves as an injectable treatment with broad-spectrum antimicrobial activity and an array of therapeutic mechanisms. In one embodiment, subject to clinical studies and characterization of cross-species immunogenicity, the composition may act as a breakthrough antimicrobial—or as a last-resort therapy for critically ill sepsis patients. In an alternative embodiment, the biologically derived antimicrobial agent represents a viable primary therapy with advantages over synthetic antibiotics, including a rapid therapeutic window. Given unmatched efficacy, an adjuvant smeLAL immunoglobulin therapy may be warranted to allow routine use if needed to address cross-species immunogenicity.
    Type: Application
    Filed: May 17, 2023
    Publication date: November 21, 2024
    Inventors: Anthony Lee Dellinger, Rachel Tinker-Kulberg, Terry Earl Brady, Melinda K. M. Goddard, Christopher L. Kepley, Lance Toland
  • Patent number: 9275553
    Abstract: A flight simulator rests on a plurality of air cushions as a hovercraft and assumes spatial attitudes depending upon the relative heights of the air cushions. Flight controls determine the volume of air supplied to each air cushion and thereby control the pitch and roll attitudes of the flight simulator. The simulator may be connected to an external support frame and may thereby be subjected to longitudinal, lateral, and rotational movements.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: March 1, 2016
    Inventor: Lance Toland
  • Publication number: 20130260343
    Abstract: A flight simulator rests on a plurality of air cushions as a hovercraft and assumes spatial attitudes depending upon the relative heights of the air cushions. Flight controls determine the volume of air supplied to each air cushion and thereby control the pitch and roll attitudes of the flight simulator. The simulator may be connected to an external support frame and may thereby be subjected to longitudinal, lateral, and rotational movements.
    Type: Application
    Filed: April 3, 2012
    Publication date: October 3, 2013
    Inventor: Lance Toland